Ashwini Vaidya, MD
Dermatology · Tulsa, OKNPI 1063495380
Payments from drug & device makers
Across 692 payments — averaging $17.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Johnson & Johnson$1K
- Lilly USA, LLC$901
- Novartis$737
- LEO Pharma Inc.$736
- Regeneron Healthcare Solutions, Inc.$724
- plus $5K from 27 others
What the payments were for
- Food & beverage$11,84198%
- Education$2092%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 166 | $3,045 |
| Johnson & Johnson | 64 | $1,101 |
| Lilly USA, LLC | 54 | $901 |
| Novartis | 42 | $737 |
| LEO Pharma Inc. | 40 | $736 |
| Regeneron Healthcare Solutions, Inc. | 31 | $724 |
| Amgen | 26 | $585 |
| Galderma Laboratories, L.p. | 33 | $465 |
| E.r. Squibb & Sons, L.L.C. | 27 | $460 |
| Arcutis Biotherapeutics, Inc. | 29 | $447 |
| Pfizer | 25 | $434 |
| Sun Pharmaceutical Industries Inc. | 23 | $394 |
| Incyte Corporation | 24 | $379 |
| Genentech USA, Inc. | 25 | $263 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 11 | $199 |
| Mayne Pharma Commercial LLC | 10 | $178 |
| UCB, Inc. | 8 | $138 |
| Bristol Myers Squibb | 9 | $123 |
| Sanofi | 5 | $94 |
| Prugen, Inc. Pharmaceuticals | 6 | $91 |
| Dermavant Sciences, Inc. | 5 | $81 |
| DUSA Pharmaceuticals, Inc. | 3 | $67 |
| Verrica Pharmaceuticals Inc. | 3 | $63 |
| Organon | 4 | $62 |
| Kyowa Kirin, Inc. | 4 | $58 |
| VYNE Pharmaceuticals Inc. | 4 | $55 |
| Sandoz | 3 | $42 |
| Biofrontera Inc. | 2 | $33 |
| Dermira, Inc. | 2 | $30 |
| Fresenius Kabi USA, LLC | 1 | $18 |
| Boehringer Ingelheim | 1 | $18 |
| Almirall LLC | 1 | $16 |
| Promius Pharma LLC | 1 | $12 |
How this compares
$12,050 in reported general payments places this provider in the 75th percentile of 114 dermatology providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cosentyx Sensoready (2 Pens)Secukinumab | 13 | $93,040 |
| Fluorouracil | 66 | $4,507 |
| Tacrolimus | 21 | $4,138 |
| Clobetasol Propionate | 90 | $3,963 |
| Metronidazole | 39 | $1,443 |
| Finasteride | 183 | $1,381 |
| Triamcinolone Acetonide | 120 | $1,223 |
| Minocycline Hcl | 63 | $1,045 |
| Betamethasone Dipropionate | 29 | $1,015 |
| Clindamycin Phosphate | 27 | $992 |
| Tretinoin | 23 | $984 |
| Ketoconazole | 32 | $741 |
| Hydroxychloroquine Sulfate | 13 | $674 |
| Desonide | 16 | $624 |
| Doxycycline Hyclate | 32 | $615 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Tulsa
- Alison FischerTulsa$1.5M
- George MonksTulsa$530K
- Kristen RiceTulsa$57K
- Jeff AlexanderTulsa$41K
- Johnathan LedetTulsa$37K
- John AshleyTulsa$24K
- Mark LehmanTulsa$17K
- Kelli LovelaceTulsa$14K
- Bernard RobinowitzTulsa$14K
- Christina KendrickTulsa$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.